(0)

DIA会员及用户请点击登录

登录

忘记用户 ID？ or 忘记密码？

Not a Member?

创建账户并加入。

CNCC

2016 年 05 月 15 日 8:30 上午 - 2016 年 05 月 18 日 5:30 下午

Beijing Chaoyang, 100062 Beijing, China

DIA China 8th Annual Meeting

概览

The DIA China Annual Meeting as the largest interdisciplinary event in Asia that brings together a global network of life sciences professionals to foster innovation that leads to the development of safe and effective products and therapies to patients.

Professionals at all levels involved in the drug discovery, development, and life cycle management of health care products, will travel from China and around the world to share their views, knowledge, experience, and cross-functional content with real-world application.

DIA China Annual Meeting had attracted nearly 1900 attendees in 2015 and will continue to be your essential partner to update knowledge and help to accelerate heath care product development.

Register

精选主题

  • CFDA Townhall
  • Special Forum – Enabling Key Capability for Innovation in China
  • Rapid Evolving China Regulatory Science – Seize the Opportunity for Driving Innovation
  • Develop Innovative Solution to Fill the Unmet Medical Needs in China – Special Focuses on Oncology, Diabetes, Cardiovascular and HCV/HBV
  • Operational Excellence – China’s Own Challenges and Unique Opportunity
  • Clinical Trial Sites in China – Bottleneck or the Anchor for Quality Clinical Trials
  • Quantitative Science – The Backbone of Evidence Based Data Generation
  • CMC & Generic Drug
  • Biologics & Biosimilar Development
  • Medical Affairs – MSLs, Marketing New Model Engagement, Compliance and Market Access
  • Key Elements in Successful Drug Activities – Medical Writing and Project Management
  • Safety Surveillance  
  • Quality System – from the Regulator, Site and Investigator's Perspectives
  • Early Stage Drug Development
  • CRO, SMO & Investigator
  • Informational Technology  -- Long Distance, Mobile Medicine & Documentation
  • Hot Topics and Late Breaker – Medical Devices and Rare Diseases 

    • 项目委员会

    • Jingsong Wang, MD
      Jingsong Wang, MD Founder, Chairman, and Chief Executive Officer
      Harbour BioMed, China
    • Haifeng Cao
      Haifeng Cao Regulatory Affairs Director
      Boehringer Ingelheim Co. Ltd, China
    • Lili Cao, MS
      Lili Cao, MS Deputy Director
      China Center for Food and Drug International Exchange (CCFDIE), NMPA , China
    • Xiaochun Cao
      Xiaochun Cao
      TIGERMED CO.,LTD., China
    • George Chen, MD, MBA
      George Chen, MD, MBA Senior VP, Global Medicines Development, Head of China Development Unit
      AstraZeneca China, China
    • Paul Dai, MD
      Paul Dai, MD Head of Clinical Operations
      TDC, Asia, Takeda, China
    • Yazhong Deng, MBA
      Yazhong Deng, MBA CEO and Founder
      Beijing Trust Medical Consulting Co. Ltd, China
    • Frank Fan, PhD
      Frank Fan, PhD Senior Medical Director
      Sanofi, China
    • Tony Guo
      Tony Guo Executive Director, Head of Biometrics China
      BeiGene, China
    • Min Wang Irwin, MD, PhD
      Min Wang Irwin, MD, PhD Venture Partner
      Qiming Weichuang Venture Capital Management (Shanghai) Co. Ltd., China
    • Amy Jiang
      Amy Jiang Head of Quality Office
      Harbour Biomed, China
    • Helen Li, MD, MBA
      Helen Li, MD, MBA Director, Emerging Market QA Asia Lead
      Pfizer Medical, China
    • Joy Li
      Joy Li Director of pharmacovigilance and medical information
      BMS China R&D, China
    • Shuting Li, MD
      Shuting Li, MD Deputy Director
      GCP Alliance, China, China
    • Vera Liang, MD
      Vera Liang, MD Sr. Director, Drug Safety Unit Regional Head - APAC
      Pfizer (China) R&D Co., Ltd., China
    • Jane LIN, MD
      Jane LIN, MD VP, Strategic Medical Affairs
      Johnson & Johnson Medical (China) Ltd., China
    • Melly Lin
      Melly Lin CMC Regulatory Policy Lead, Pharma Technical Regulatory
      F. Hoffmann-La Roche Ltd, Switzerland
    • Jessica Liu, MD
      Jessica Liu, MD VP, Head of Merges and Acquisition Management Department
      Tigermed Consulting Co., Ltd, China
    • Roger (Peng) Qu, PhD
      Roger (Peng) Qu, PhD Head of Clinical Statistics
      Pfizer China R&D Center, China
    • Hualong Sun
      Hualong Sun General manager
      Meta Clinical Technical Co. Ltd, China
    • Xiaoling Wang
      Xiaoling Wang Clinical Documentation
      Clinical Science Operation, Sanofi R&D China, China
    • Xiuqin Wang, MD
      Xiuqin Wang, MD Vice Director of Scientific Research Dept.
      Jiangsu Province Hospital, China
    • Jielai Xia, PhD
      Jielai Xia, PhD Director, Department of Medical Statistics
      Air Force Military Medical University, China
    • Jack Xu, MD, MS
      Jack Xu, MD, MS Senior Vice President
      Shanghai Clinical Research Center (SCRC), China
    • Charles Yan
      Charles Yan Vice President, Head of Clinical Data Science Center
      Jiangsu Hengrui, China
    • James Yan
      James Yan Executive Vice President, Head of Early Development and Drug Safety,
      Zai Lab, China
    • Xiaojun (Wendy) Yan, MD, MBA
      Xiaojun (Wendy) Yan, MD, MBA Senior Vice President, Chief Regulatory Officer
      BeiGene (Beijing) Co., Ltd., China
    • Joe Zhang
      Joe Zhang Co-founder and CEO
      BJ Bioscience Inc., China
    • Mingping Zhang
      Mingping Zhang Vice President, Technical
      PAREXEL, United States
    • Ling Zhen
      Ling Zhen
      Quintiles, China
    • Xiaoxiang Chen
      Xiaoxiang Chen Vice President
      Boehringer Ingelheim Shanghai Pharm. Co. Ltd, China
    • Carol Zhu, MBA
      Carol Zhu, MBA Vice President, Portfolio and Project Management
      JW Therapeutics, China
    • Janet Lu, MS, RPh
      Janet Lu, MS, RPh Head of Regulatory Asia Pacific
      Roche , China
    • Ling Su, PhD
      Ling Su, PhD Research Fellow
      Shenyang Pharmaceutical University, Yeehong Business School, China
    • Ning Xu, MD, MBA
      Ning Xu, MD, MBA Executive Vice President, Head of Global Clinical Operations, Zailab
      Zai Lab, China

    获得信息并保持参与

    不要错失任何机会——请加入我们的邮件列表，了解DIA的观点和事件。